(Press-News.org) LOS ANGELES (July 21, 2014) – Investigators at the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute are developing a novel, multistep investigational treatment for one of the most complex and difficult-to-treat forms of the disease, locally advanced pancreatic cancer.
Locally advanced pancreatic cancer has the lowest survival rate of any solid tumor, with a cumulative five-year survival rate of only 4 percent for all stages of disease. Surgery is rarely an option for patients because tumors often involve vital blood vessels. Chemotherapy and radiotherapy given concurrently remain the mainstay treatment, yet to-date, no treatment has had a significant impact on improving outcomes.
"To move the needle forward toward prolonged survival and better treatment outcomes, our research team created a combined investigational regimen for patients with locally advanced pancreatic cancer," said Richard Tuli, MD, PhD, a radiation oncologist in the Department of Radiation Oncology and a member of the Samuel Oschin Comprehensive Cancer Institute. "Coupled with this research treatment, we are also looking to identify patient biomarkers, or molecular signatures, that may provide clues to how, and why, some patients respond better than others."
Tuli was the first author of a pre-clinical study recently published in the journal Translational Oncology. Using animal models, the study evaluated a novel treatment for pancreatic cancer that combines radiation, chemotherapy and treatment with a specific drug that can inhibit the repair of cancer cells damaged by chemotherapy and radiation. Successful research findings led to a clinical trial now enrolling eligible patients.
Many standard cancer treatments for pancreatic cancer, including chemotherapy and radiation therapy, kill tumors by damaging their DNA. When such DNA damage occurs, proteins known as PARPs move to the site of damage and begin to mend these broken strands of DNA, allowing cancerous cells and tumors to recover, grow and proliferate, thereby escaping the effects of treatment.
With this knowledge, researchers combined radiation with a drug to prevent PARP from repairing cancerous cells. When the treatment was given to laboratory mice, the combination resulted in prolonged survival.
"Based on this research, we are now conducting a first-in-human study combining the PARP inhibitor with radiation and chemotherapy in patients with locally advanced pancreatic cancer, with an ultimate goal of improving survival rates and treatment outcomes," said Tuli.
The investigational treatment regimen also could prove beneficial to patients with other forms of cancer. Recent research findings suggest PARP could be beneficial for patients who carry either or both the BRCA1 or BRCA2 mutations. "Normal" BRCA genes help suppress tumor formation and repair damaged DNA; the mutated genes' protective mechanisms are compromised, leading to genetic defects that result in cancer. But the "defective" repair capability is a process that may be exploited by treatments, such as PARP inhibition, which further impairs the ability of tumors to repair their own DNA after insult with radiation.
In addition to adding a novel PARP inhibitor to the regimen, investigators are seeking to identify other markers related to DNA damage that could provide a molecular signature, or biomarker, to forecast how a patients' tumor would respond to treatment and help guide personalized treatment options in the near future.
"Identifying individual biomarkers to better understand how a patient may respond to treatment is an essential step toward personalizing medicine for every individual," said Steven Piantadosi, MD, PhD, director of the Samuel Oschin Comprehensive Cancer Institute and Phase One Foundation Chair. "It is the goal of our cancer institute to combine the most advanced patient-centered clinical care with innovative research that expands treatment options and improves outcomes. This is especially true in pancreatic cancer, which has been long known as a challenging disease to fight."
INFORMATION:
Patients interested in pancreatic cancer or other clinical trials at Cedars-Sinai may visit http://cancertrialinfo.csmc.edu or contact Jaime Richardson, RN, clinical trial navigator at the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute, at 310-423-2133 or cancer.trial.info@cshs.org.
The clinical trial is funded in part by a grant from PHASE ONE and its board member Diane V. Allen, in memory of her husband Bryan J. Axelrood. The PHASE ONE organization is a nonprofit dedicated to ensuring the Southern California community has access to the most promising novel therapies for those diagnosed with cancer.
Clinical Trial: Phase I study of veliparib (ABT-888) in combination with gemcitabine and intensity-modulated radiation therapy in patients with locally advanced, unresectable pancreatic cancer.
Study Citation: Translational Oncology. 2014 May: Radiosensitization of Pancreatic Cancer Cells In Vitro and In Vivo through Poly (ADP-ribose) Polymerase Inhibition with ABT-888. Authors from the Department of Radiation Oncology and Molecular Radiation Sciences at Johns Hopkins University School of Medicine participated in this research. Study funding was supported by Blum-Kovler, the Pancreatic Cancer Action Network, the AACR Career Development Award and the Claudio X. Gonzalez Family Foundation.
Unique study focuses on combined treatment approach for locally advanced pancreatic cancer
The study and accompanying clinical trial aim to identify tumor biomarkers and provide clues into individual treatment response
2014-07-22
ELSE PRESS RELEASES FROM THIS DATE:
Vanderbilt discovery may advance colorectal cancer diagnosis and treatment
2014-07-22
A Vanderbilt University-led research team has identified protein "signatures" of genetic mutations that drive colorectal cancer, the nation's second leading cause of cancer deaths after lung cancer.
The technological tour de force, described in the current issue of the journal Nature as the first integrated "proteogenomic" characterization of human cancer, "will enable new advances" in diagnosing and treating the disease, the scientists concluded.
"It's a first-of-its-kind paper. I think it's a very important advance in the field," said senior author Daniel Liebler, ...
Low-income students in charter high schools less likely to engage in risky behavior
2014-07-22
A new UCLA-led study suggests that a higher quality educational environment may help improve health outcomes
Low-income minority adolescents who were admitted to high-performing public charter high schools in Los Angeles were significantly less likely to engage in risky health behaviors than their peers who were not admitted to those schools, according to a new UCLA-led study.
These students also scored significantly better on California state standardized math and English tests.
While numerous previous studies have shown a link between health and K-12 education, ...
Strategies to preserve myelin during secondary degeneration following neurotrauma
2014-07-22
Researchers at the University of Western Australia, led by Associate Professor Melinda Fitzgerald, have discovered that preventing abnormalities in the insulating sheath surrounding nerve cells is associated with better function following neurotrauma.
Following injury to the central nervous system, damage spreads away from the initial impact in a process known as secondary degeneration. Dr Fitzgerald emphasises that "In order to develop treatments for secondary degeneration, we need to understand the biochemical reactions that occur in tissue that succumbs to spreading ...
Ginkgo biloba enhances neurogenesis and improves recovery following a stroke in mice
2014-07-22
Led by Dr. Zahoor A. Shah, Dr. Shadia E. Nada and Jatin Tulsulkar (graduate student), researchers at the University of Toledo, Toledo, OH, have discovered that mice treated with Ginkgo biloba 4 hours after inducing experimental stroke and then daily for seven days had improved recovery and less brain damage than the control mice. It was also observed that Ginkgo biloba treated mice had enhanced neurogenesis, partly due to the increased protein expression of hemeoxygenase 1, an antioxidant gene that also has a role in neurogenesis. Pertinently, mice lacking the hemeoxygenase ...
Fires are a major cause of wind farm failure, according to new research
2014-07-22
*** UPDATE TO NEWS RELEASE: 'Fires are a major cause of wind farm failure, according to new research' ***
Message to news release subscribers from Imperial College London Press Office:
Following discussion with reporters we wish to draw attention to further information relating to the News Release issued under embargo for Thursday 17 July 2014: "Fires are a major cause of wind farm failure, according to new research". A version of this note will be appended to the online news release and news story and both will be updated accordingly.
1. The purpose of the research ...
Cleveland Clinic researchers discover neuroprotective role of immune cell
2014-07-22
July 22, 2014, Cleveland: A type of immune cell widely believed to exacerbate chronic adult brain diseases, such as Alzheimer's disease and multiple sclerosis (MS), can actually protect the brain from traumatic brain injury (TBI) and may slow the progression of neurodegenerative diseases, according to Cleveland Clinic research published today in the online journal Nature Communications.
The research team, led by Bruce Trapp, PhD, Chair of the Department of Neurosciences at Cleveland Clinic's Lerner Research Institute, found that microglia can help synchronize brain firing, ...
High school lacrosse players at risk of concussions other injuries
2014-07-22
AURORA, Colo. (July 22, 2014) – With over 170,000 students now playing high school lacrosse, more and more are being exposed to injuries during practice and competition, according to a new study from the Colorado School of Public Health and the Center for Injury Research and Policy at Nationwide Children's Hospital in Columbus, Ohio.
The study, published online today by The American Journal of Sports Medicine, found that high school lacrosse players experienced 1,406 injuries over the four academic years from 2008 through 2012. The overall injury rate was 20 per 10,000 ...
New planthopper species found in southern Spain
2014-07-22
Not much is known about the the genus of planthopper known as Conosimus, which now includes six species after a new one was recently discovered in the southern part of the Iberian Peninsula in the Spanish city of Jaen. A description of it appears in the open-access Journal of Insect Science (see http://www.insectscience.org/14.92/).
The new species, Conosimus baenai, has been named after Manuel Baena, a Spanish hemipterologist, for his contributions to the taxonomy of Iberian Hemiptera.
Conosimus baenai differs in appearance from the other species in the Conosimus genus ...
Middle East Respiratory Syndrome coronavirus detected in the air of a Saudi Arabian camel barn
2014-07-22
Saudi Arabian researchers have detected genetic fragments of Middle East Respiratory Syndrome coronavirus (MERS-CoV) in the air of a barn holding a camel infected with the virus. The work, published this week in mBio®, the online open-access journal of the American Society for Microbiology, indicates that further studies are needed to see if the disease can be transmitted through the air.
MERS, a serious viral respiratory illness caused by the coronavirus, has been identified in 699 people as of June 11, according to the World Health Organization; 209 people have died ...
Viral therapy could boost limb-saving cancer treatment
2014-07-22
Viruses designed to target and kill cancer cells could boost the effectiveness of chemotherapy to the arms and legs and help avoid amputation, a new study reports.
Scientists at The Institute of Cancer Research, London, tested the effectiveness of a genetically engineered version of the virus used to vaccinate against smallpox.
They found use of the virus alongside isolated limb perfusion chemotherapy – given directly to blood vessels supplying the affected arm or leg as an alternative to amputation – was more effective in rats than either treatment on its own.
The ...
LAST 30 PRESS RELEASES:
Special issue of APA’s official journal focuses on psychedelic medication
Geneticist unlocks mysteries of childhood psychiatric disorders through innovative research
New study uncovers key insights into protein interactions in Duchenne muscular dystrophy, paving way for more targeted therapies
Revolutionizing fragrance design using deep neural networks (DNNs) scent profiles from chemical data
Custom-fit bone grafts: the future of craniomaxillofacial surgery
A new ‘molecular lantern’ detects brain metastasis in mice by inserting a probe thinner than a hair into the brain
McGill scientist reveals how early life experiences reshape our genes and brain health
Renowned scientist reveals vital link between inflammation and depression through groundbreaking research
Medical researcher explores economic impact of psychedelic therapy implementation
Improving immunotherapies for kidney cancer
Billing patients for portal messages could decrease message volume and ease physician workload
Study of Sherpas highlights key role of kidneys in acclimatization to high altitudes
Smartphone app can help reduce opioid use and keep patients in treatment, UT Health San Antonio study shows
Improved health care value cannot be achieved by hospital mergers and acquisitions alone
People who are immunocompromised may not produce enough protective antibodies against RSV after vaccination
Does coffee prevent head and neck cancer?
AI replaces humans in identifying causes of fuel cell malfunctions
Pitfalls of FDA-approved germline cancer predisposition tests
A rising trend of 'murderous verbs' in movies over 50 years
Brain structure differences are associated with early use of substances among adolescents
Pain coping skills training for patients receiving hemodialysis
Trends of violence in movies during the past half century
Major depressive disorder and driving behavior among older adults
John Howington, MD, MBA, FCCP, to become the 87th President of the American College of Chest Physicians
Preclinical study finds surges in estrogen promote binge drinking in females
Coming AI economy will sell your decisions before you take them, researchers warn
NASA’s Parker Solar Probe makes history with closest pass to Sun
Are we ready for the ethical challenges of AI and robots?
Nanotechnology: Light enables an "impossibile" molecular fit
Estimated vaccine effectiveness for pediatric patients with severe influenza
[Press-News.org] Unique study focuses on combined treatment approach for locally advanced pancreatic cancerThe study and accompanying clinical trial aim to identify tumor biomarkers and provide clues into individual treatment response